122892-31-3COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC.ClZTOUXLLIPWWHSR-UHFFFAOYSA-NSee also: Itopride (has active moiety).
122892-31-3DTXSID5046693CHEMBL2139257Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H400 (97.6%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]
P273, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 42 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
DescriptionItopride, a gastroprokinetic benzamide derivative was launched in Japan for the relief of gastrointestinal symptoms in patients with chronic gastritis. ltopride is a dopamine D2-receptor antagonist that stimulates acetylcholine (Ach) release on the postganglionic cholinergic neurons to cause Ach accumulation at muscarinic receptors and, therefore, enhances Ach-induced gastric contractions. In animal models, itopride was reported to increase GI transit and gastric emptying.
UsesDopamine D2-receptor antagonist with anticholinesterase activity. Gastroprokinetic
UsesDopamine D2 receptor blockade,acetylcholinesterase inhibitor
UsesAnti-Spasmodics
General DescriptionItopride hydrochloride is a new prokinetic drug.
No reaction records under the current filter.
Loading…